| Serial Number | 79213966 |
| Word Mark | MENOVO |
| Filing Date | Thursday, January 12, 2017 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, December 13, 2024 |
| Registration Number | 5477856 |
| Registration Date | Tuesday, May 29, 2018 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 13, 2018 |
| Description of Mark | The mark consists of the wording "MENOVO" inside of an oval formed by a line with a break on the left bottom with a vertical line extending above the break, and a break on the right top with a vertical line extending below the break. |
| Goods and Services | Medicines for human purposes for antibiotics, the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer, gastrointestinal diseases and coughs; syrups for pharmaceutical purposes for the treatment of coughs; pharmaceutical preparations for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; chemico-pharmaceutical preparations for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; analgesics; drugs for medical purposes for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; vermicide for human or veterinary use; anthelmintics for human or veterinary use; medical pills for the relief of pain and for the treatment of headache, hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; capsules for pharmaceutical purposes for the relief of allergy and pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; sedatives; biological preparations for medical purposes for antibiotics, for the prevention and treatment of infectious diseases and for the treatment of cancer; chemical preparations for medical purposes for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; injectable pharmaceuticals for the treatment of cancer, immunosuppression and infection; medicinal preparations for the mouth to be applied in the form of tablets for the relief of pain and for the treatment of hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases; active pharmaceutical ingredient for the relief of pain and for the treatment of inflammation, hypertension, hyperlipidemia, high thrombosis, diabetes, heart disease, depression, immunosuppression, tuberculosis, infection, cancer and gastrointestinal diseases |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, December 13, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NINGBO MENOVO PHARMACEUTICAL CO., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Zhejiang 315000 CN |
| Party Name | NINGBO MENOVO PHARMACEUTICAL CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Zhejiang 315000 CN |
| Party Name | NINGBO MENOVO PHARMACEUTICAL CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Zhejiang 315000 CN |
| Event Date | Event Description |
| Thursday, August 10, 2017 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, August 15, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 15, 2017 | ASSIGNED TO EXAMINER |
| Thursday, August 17, 2017 | NON-FINAL ACTION WRITTEN |
| Friday, August 18, 2017 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, August 19, 2017 | APPLICATION FILING RECEIPT MAILED |
| Monday, August 21, 2017 | REFUSAL PROCESSED BY MPU |
| Wednesday, January 31, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 21, 2017 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, September 9, 2017 | REFUSAL PROCESSED BY IB |
| Wednesday, January 31, 2018 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, January 31, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 1, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 2, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 21, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 13, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 13, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 29, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, August 29, 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, September 14, 2018 | GENERIC MADRID TRANSACTION SENT TO IB |
| Friday, May 19, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, September 14, 2018 | GENERIC MADRID TRANSACTION CREATED |
| Friday, November 16, 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, May 29, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, December 13, 2024 | CANCELLED SECTION 71 |